Opus Genetics, Inc. (IRD) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 5 sales totalling $214K. Most recent filing: Sept. 11, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 11, 2026 filed Sept. 9, 2026 | Magrath George Chief Executive Officer | — | +316,616 | — | No | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 3, 2026 | Gagnon Robert E. Chief Financial Officer | −$127,212 | 28,000 | −5% | No | |
|
|
||||||
| Sept. 8, 2026 | Gallagher Cam Director | $901,961 | 1,568,628 | — | No | |
|
|
||||||
| July 27, 2026 filed July 23, 2026 | SCHACHLE JOSEPH K Chief Operating Officer | −$13,653 | 4,644 | −2% | No | |
|
|
||||||
| July 27, 2026 filed July 23, 2026 | YERXA BENJAMIN R President | −$22,064 | 7,429 | −1% | No | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free